Hepatoblastoma constitutes 79% of all liver tumors in children with an annual incidence of 1.2 cases per million in children [1]. 90% of hepatoblastomas in pediatric population is seen below the age of four [2]. Plasma alpha protein dosage is a sensitive cum specific marker for the early diagnosis and monitoring of hepatoblastoma. There are reported cases of prenatally identified fetal hepatoblastoma [3][4][5][6]. The salient feature in all these cases is the sonographic finding of large fetal abdominal mass. Extensive hemmorhage within the tumor was a cause for fetal death in these cases. Focal nodular hyperplasia, adenoma, hepatic cysts, metastatic tumors and a fetus in fetu are the hepatic tumors other than hepatoblastoma [4]. Even though it is very rare, metastasis of fetal neuroblastoma to the liver in utero and maternal malignancy metastatic to the fetal liver are also reported [4,7,8]. Anemia, moderate leukocytosis and thrombocytosis along with upper quadrant abdominal mass and abdominal distension are the common symptoms of hepatic neoplasms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.